β¨ Health Notices
19 MARCH 2009 NEW ZEALAND GAZETTE, No. 35 941
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Coldrex PE Phenylephrine Sinus
Active Ingredients: Paracetamol 500mg
Phenylephrine hydrochloride 5mg equivalent to 4.1mg phenylephrine
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Australia Pty Limited, Consumer Healthcare, Ermington, New South Wales, Australia
Product: Fludarabine Ebewe
Active Ingredient: Fludarabine phosphate 25mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturer: EBEWE Pharma GmbH Nfg KG, Unterach am Attersee, Austria
Product: Paracetamol (Medix)
Active Ingredient: Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: Nova Pharmaceuticals NZ Limited
Manufacturer: Marksans Pharma Limited, Verna, Goa, India
Product: Paracetamol (Home Brand)
Active Ingredient: Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: Nova Pharmaceuticals NZ Limited
Manufacturer: Marksans Pharma Limited, Verna, Goa, India
Dated this 13th day of March 2009.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2496
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Baraclude
Active Ingredient: Entecavir monohydrate 0.05mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Company, Mt Vernon, Indiana, United States of America
Product: Baraclude
Active Ingredient: Entecavir monohydrate 0.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare13 March 2009
Medicines, Distribution, Consent, Paracetamol, Phenylephrine, Fludarabine
- ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
π₯ Consent to the Distribution of a Changed Medicine
π₯ Health & Social WelfareMedicines, Distribution, Consent, Baraclude, Entecavir
NZ Gazette 2009, No 35